Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS)
which initiates rapid signal transmission in the synapse before its re-uptake into the …

The astrocytic glutamate transporters excitatory amino acid transporters 1 and 2 (EAAT1 and
EAAT2) play a key role in nervous system function to maintain extracellular glutamate levels …

The term cytokine storm has become a popular descriptor of the dramatic harmful
consequences of the rapid release of polypeptide mediators, or cytokines, that generate …

Preterm birth complications are the leading cause of child death worldwide and a top global
health priority. Among the survivors, the risk of life-long disabilities is high, including cerebral …

Cohort-based whole exome and whole genome sequencing and copy number variant
(CNV) studies have identified genetic etiologies for a sizable proportion of patients with …

Aim To conduct a systematic review of phenotypic definition and case ascertainment in
published genetic studies of cerebral palsy (CP) to inform guidelines for the reporting of …

Cerebral palsy (CP) is a clinical term used to describe a spectrum of movement and posture
disorders resulting from non-progressive disturbances in the develo** fetal brain. The …

Cerebral palsy (CP) is a leading cause of neurological disability among young children.
Congenial and adverse perinatal clinical conditions, such as genetic factors, perinatal …

Neonatal brain damage and age-related neurodegenerative disease share many common
mechanisms of injury involving mitochondriopathy, oxidative stress, excitotoxicity …

Despite improvements in viability, the long-term neurodevelopmental outcomes of preterm
babies remain serious concern as a significant percentage of these infants develop …